HAVN Life Sciences Inc. (HAVLF)

Market Cap	621.26K
Revenue (ttm)	440.11K
Net Income (ttm)	-11.78M
Shares Out	n/a
EPS (ttm)	-1.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	157
Average Volume	4,105
Open	0.0010
Previous Close	n/a
Day's Range	0.0010 - 0.0010
52-Week Range	0.0001 - 0.0360
Beta	-0.61
RSI	44.58
Earnings Date	Dec 20, 2024

About HAVN Life Sciences

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: HAVLF

Financial Performance

Financial numbers in CAD